Memorial Sloan Kettering Cancer Center
- Country
- πΊπΈUnited States
- Ownership
- Private
- Established
- 1884-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.mskcc.org
A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
- Conditions
- First Posted Date
- 2022-10-05
- Last Posted Date
- 2024-12-09
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 160
- Registration Number
- NCT05568420
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
A Study of RP-3500 in Combination With Standard Radiation Therapy in People With Solid Tumor Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-10-04
- Last Posted Date
- 2024-10-31
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 84
- Registration Number
- NCT05566574
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center at Suffolk-Commack (All Protocol Activities), Commack, New York, United States
πΊπΈMemorial Sloan Kettering Westchester (All Protocol Activities), Harrison, New York, United States
πΊπΈMemorial Sloan Kettering Monmouth (All Protocol Activities), Middletown, New Jersey, United States
A Study of 68Gallium PSMA-PET/CT Scans in People With Bladder Cancer or Skin Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-10-03
- Last Posted Date
- 2024-08-16
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 20
- Registration Number
- NCT05562791
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
Tablet-based Mobile Health Ultrasound for Point-of-care Breast Cancer Diagnosis in Nigeria (Mobile Health: Technology and Outcomes in Low and Middle-Income Countries)
- Conditions
- Interventions
- First Posted Date
- 2022-09-30
- Last Posted Date
- 2024-10-18
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 900
- Registration Number
- NCT05561842
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
π³π¬Lagos University Teaching Hospital, Idi-Araba, Lagos, Nigeria
π³π¬Olabisis Onabanjo University Teaching Hospital (Data Collection Only), Sagamu, Ogun State, Nigeria
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- Conditions
- Interventions
- First Posted Date
- 2022-09-29
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 119
- Registration Number
- NCT05559853
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York, New York, United States
A Study of Belantamab Mafodotin in Combination With Nirogacestat and Pomalidomide in People With Multiple Myeloma That Has Not Responded to Treatment or Has Come Back After Treatment
- Conditions
- Interventions
- First Posted Date
- 2022-09-27
- Last Posted Date
- 2024-11-08
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 9
- Registration Number
- NCT05556798
- Locations
- πΊπΈ
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
πΊπΈMemorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
πΊπΈMemorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
A Study of Decreasing Radiation Therapy and Chemotherapy in People With Head and Neck Cancer
- First Posted Date
- 2022-09-16
- Last Posted Date
- 2024-04-26
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 36
- Registration Number
- NCT05544136
- Locations
- πΊπΈ
Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey, United States
πΊπΈMemorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown, New Jersey, United States
πΊπΈMemorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale, New Jersey, United States
A Study of Cognitive Health in Survivors of Prostate Cancer
- Conditions
- Interventions
- First Posted Date
- 2022-09-15
- Last Posted Date
- 2024-07-03
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 200
- Registration Number
- NCT05540782
- Locations
- πΊπΈ
Memorial Sloan Kettering Nassau, Uniondale, New York, United States
πΊπΈMemorial Sloan Kettering Bergen, Montvale, New Jersey, United States
πΊπΈMemorial Sloan Kettering Cancer Center Suffolk - Commack, Commack, New York, United States
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
- Conditions
- Interventions
- First Posted Date
- 2022-09-14
- Last Posted Date
- 2024-10-29
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 60
- Registration Number
- NCT05540392
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center Suffolk - Commack, Commack, New York, United States
πΊπΈMemorial Sloan Kettering Bergen, Montvale, New Jersey, United States
πΊπΈMemorial Sloan Kettering Monmouth, Middletown, New Jersey, United States
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
- Conditions
- Interventions
- First Posted Date
- 2022-09-14
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Memorial Sloan Kettering Cancer Center
- Target Recruit Count
- 40
- Registration Number
- NCT05540340
- Locations
- πΊπΈ
Memorial Sloan Kettering Cancer Center, New York, New York, United States